^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
BPB-101
i
Other names: BPB-101
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Betta Pharma
Drug class:
PD-L1 inhibitor, TGFβ inhibitor, GARP-TGFβ complex inhibitor
Related drugs:
over1year
BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors (clinicaltrials.gov)
P1/2, N=388, Recruiting, Betta Pharmaceuticals Co., Ltd. | Not yet recruiting --> Recruiting
Enrollment open • Metastases
|
BPB-101
over1year
BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors (clinicaltrials.gov)
P1/2, N=388, Not yet recruiting, Betta Pharmaceuticals Co., Ltd.
New P1/2 trial • Metastases
|
BPB-101
Share via
